Tamoxifen Citrate (KAISER FOUNDATION HOSPITALS)
Welcome to the PulseAid listing for the Tamoxifen Citrate drug offered from KAISER FOUNDATION HOSPITALS. This Estrogen Agonist/Antagonist [EPC],Selective Estrogen Receptor Modulators [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | KAISER FOUNDATION HOSPITALS |
NON-PROPRIETARY NAME: | Tamoxifen Citrate |
SUBSTANCE NAME: | TAMOXIFEN CITRATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Estrogen Agonist/Antagonist [EPC],Selective Estrogen Receptor Modulators [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-01-12 |
END MARKETING DATE: | 0000-00-00 |
Tamoxifen Citrate HUMAN PRESCRIPTION DRUG Details:
Item Description | Tamoxifen Citrate from KAISER FOUNDATION HOSPITALS |
LABELER NAME: | KAISER FOUNDATION HOSPITALS |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 10(mg/1) |
START MARKETING DATE: | 2017-01-12 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0179-0224_c2ed44db-3334-4a0f-8725-ab7b2e95431d |
PRODUCT NDC: | 0179-0224 |
APPLICATION NUMBER: | ANDA075797 |
Other TAMOXIFEN CITRATE Pharmaceutical Manufacturers / Labelers: